The Royal Adelaide Hospital (RAH) continues to be a centre for excellence in medical research.
All current clinical trials have moved into the new site or within the North Terrace precinct known as Adelaide BioMed City - set to become one of the largest health and life sciences clusters in the southern hemisphere.
The majority of researchers have been allocated space within the RAH, while a small number whose work aligns with South Australian Health and Medical Research Institute (SAHMRI) research pillars will be located in this facility, further strengthening this critical partnership.
Face-to-face patient consultations occur within the outpatient, inpatient or day treatment areas.
Having all current clinical trials based in the heart of the Health and Biomedical Precinct, with the majority at the RAH, is an excellent outcome and follows substantial consultation with research and administration staff.
At any one time the RAH has approximately 140 staff working on around 280 clinical trials.
These important trials will deliver potentially lifesaving medical breakthroughs and are vital to South Australia’s standing in the medical and research worlds.